{"title":"纳曲酮、阿坎酸在酒精使用障碍治疗综述中显示出最强效果","authors":"","doi":"10.1002/pu.31133","DOIUrl":null,"url":null,"abstract":"<p>A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 3","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments\",\"authors\":\"\",\"doi\":\"10.1002/pu.31133\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"35 3\",\"pages\":\"4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31133\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments
A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
